Which claims deserve a pause?

Prescription medicine offered without a prescription

Federal law bars providing prescription medicines without a valid prescription as of September 26, 2026. A

The FDA, the federal medicine agency, places this among its online-pharmacy warning signs. A

“Research use only” paired with treatment claims

Some labels use “for research use only.” Others use “not for human consumption,” which means not intended for people to take. B

The FDA warns against weight medicines sold for people to use with research labels as of September 26, 2026: their quality is not known, and they may harm people. C

A research label is not evidence that a product is a reviewed treatment. B

Approval claims built on registration or a code

A facility’s FDA registration gives no FDA approval to that facility or its products as of September 26, 2026. D

NDC is short for National Drug Code; this number identifies a drug product in the government’s list. An offer may cite an “NDC number” as proof of approval; that number is not proof. E

A medicine made as a custom order is called compounded; as of that date, it lacks FDA approval. F

A treatment menu without a health check

The Federation of State Medical Boards adopted guidance in May 2026 saying that picking treatment only from a menu falls short of the care standard. G

That guidance is a model for boards, not a separate Arizona law. G

Have the clinician explain how your health needs will be checked and how you can ask follow-up questions.

A low price beside other troubling signs

The FDA flags unusually cheap offers as a reason for caution alongside other warning signs; price alone does not show a service is false. H

Read the full terms, ask for the pharmacy name, and check the relevant license records.